About This Expo
TIDES Asia: Oligonucleotide and Peptide Therapeutics 2027 is Asia's premier forum dedicated to accelerating therapeutic breakthroughs from discovery to market. This exclusive gathering unites leaders in oligonucleotide, peptide, mRNA, and genome editing from across the Asia-Pacific region and Europe. Attendees will converge to share cutting-edge strategies in discovery, development, and CMC, fostering collaborative innovation to advance next-generation therapeutics. The event offers an invaluable opportunity for pharmaceutical companies and experts to explore an Advanced Technology Showcase for R&D tools and solutions, and a Research Showcase Opportunity to present scientific breakthroughs. It's an essential platform for those seeking to stay ahead in the rapidly evolving fields of biotechnology and pharmaceuticals, providing insights into in-depth development strategies, trends, and regulatory updates.